Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
All is looking strong on the USRM front!
This is BIG!!! Thank you the info on the webinar. Everything is positive most important being the Jeff Sessions bill. The fact that the guidelines referring to minimal manipulation can NOT be enforced is so huge. Remember the stock price took a huge hit when the guidelines came out and there is no way a bill to have the FDA control one’s own stem cells gets passed in congress this day in age. I say take it to congress which would create more awareness and pour some more fuel on this fire which is getting more positive awareness and testimonials daily. All of the other info from the webinar....on working with lawyers to do this the right way, delivering Myocell in overseas clinics, increased public demand for treatments, and the ability to inject cells domestically in the heart is all perfect news! This is all working out nicely for USRM and they seem to be working with the FDA not against them. The FDA needs a “poster child”cutting edge leading clinic who can educate and open their minds to these new treatments.(face it there are bad clinics and doctors out there which is why the FDA has taken action)The current FDA isn’t going to stand in the way of this leader and world renowned company they just want to be involved and respected. Way too much momentum and progress has been made. This stock hit .17 last year when RMAT was just a shot in the dark, USRM has come so far since then and has made tremendous calculated steps on all fronts in getting this mainstream and safe. All to ultimately help people. How awesome! This will be sooooooooo huge!!! This is all just my humble opinion....(I think about the future when my now young kids grow up and will laugh at how I am so old I didn’t have stem cell Treatments growing up. When they graduate college and I hand each of them the keys to their Ferrari’s...I will make sure and let them know I may not have grown up with stem cell treatments...but lucky for us I was a major investor! BAM!)
Inexperienced Fools trying to flip should flip other tickers in and hold here. There is clearly big news which will be released any day IMO, why risk a huge amount of upside over a 10% flip. Nobody can Time this! With the volatility you can go get a 10% flip on a major exchange these days! Short sided and inexperienced traders. People who haven’t done their DD can go “flip”themselves! patience here folks
This thing is a slug! Lol
MM’s will slowly lose their control not this. The wall is a joke, and everyone knows it. We need substantial news to break through, which we will get IMO.
Looking good!
Dang...only got 50K of the 250K I wanted at .0195. Probably last opportunity to grab anything south of .02. Fools who are selling at this low but thank you!
I’ll take some more shares here!
More shares into stronger hands today! Well done
People should pick up as many shares before this potentially record breaking report comes out in February. That along with the Men’s Health article should send this to .06+ And as soon as we get a partner .10+ then with RMAT .50+. No better opportunity in the OTC Markets that can back up the hype with actual revenues and demand IMO.
Another encouraging piece of news! This guy is connected in the sports world and extremely influential. Men’s Health = lots of readers. Way to go USRM, and the info on being the company with the most in clinic treatments as well...what do you think that will translate to in revenue which we should see early next month on the report. IMO record revenues again! Now let’s take down these B/S walls and get moving here!
I am glad you appreciated this enough to save it. It has been a long ride here But I am optimistic it will pay off!
I have order in for 250k at .0251 (all week)anyone wanna fill me? Of course this doesn’t show on level 2 why would the mm’s wanna show support levels from real buyers!
No volume or meaningful action here until substantial news. Which will come soon IMO. We all know a good report is on its way but sure would be nice to hear about a partnership as well!
People need to put their money where their mouths are. I am accumulating on days like this!
The lawsuit nonsense IMO is an opportunity to accumulate more cheap shares. With revenues increasing quarter after quarter coupled with the demand in this space,it’s just a matter of time here. IMO there will be a major partnership announced in 2018, a company that has the $$$ to bring this to the next level. As demand for stem cell treatments increases daily and people are educated on this medical technology, some big company will see that as an opportunity to capitalize on. In fact we saw this with The potential 5 Million investment earlier this year until the FDA pulled the rug out from the RMAT with the lack of a clear path. Since then the path to RMAT is more clear, the FDA seems to be more open to this space as a major healthcare solution, and USRM announced RMAT is still in play and partnerships are being explored. IMO everything is setting up nicely. Those of us that have been here a while know that when it runs it runs fast and it’s hard to get shares. Enjoy these times as long as Time is on your side of course.
Bitter cold forecast for Xmas in the NE. “Winter is here” is all over the news. If this doesn’t run up hard over the next couple of weeks I would be surprised. Don’t let the powers that be take your cheap shares!
DGAZ went from 22 to 40 in 1 1/2 months so this can run too l, but I am in agreement with the underlying frustration with the current pps. Ask yourself this, how much lower can this go? I would be upset losing a bit more if I don’t sell, but furious if I sold at bottom and missed run back up!
I think people have had enough of this garbage!
Mesoblast gets RMAT designation, USRM should not be far behind!
https://finance.yahoo.com/news/mesoblast-receives-fda-regenerative-medicine-110000885.html;_ylc=X1MDMTE5Nzc4NDE4NQRfZXgDMQRfeXJpZAMwMTQ2dGwxZDNuaTYxBGcDZFhWcFpEeHVjejQxTURoa01HTTBNUzA1TldZMkxUTTJNVEF0WWpRd05TMHdOMlV4TjJVNU9XRTRaVFoxZFdsa1BHNXpQazFGVTA4PQ0KBGxhbmcDZW4tVVMEb3JpZ19sYW5nA2VuBG9yaWdfcmVnaW9uA1VTBHBvcwMwBHJlZ2lvbgNVUwRzeW1ib2wDTUVTTw--?.tsrc=applewf
Patience pays off. Strong financials and creating awareness combined with deregulation will send this to the moon. IMO The risk/reward with this company is crazy positive! Looking forward to Comella’s presentation on Thursday and more upside to come!
Here we go!
Would be nice to get some news above and beyond KC’s Facebook post about patients rights being ignored by FDA. This shows me USRM is disappointed in the framework. How about some info on how USRM intends to navigate going forward. Some say silence is golden but with all the shareholders have been through with this company we deserve news on how the company plans to proceed. Surely over the last several months they have anticipated this framework going this direction, so Question is
....did they plan accordingly? We will see but the silence is not becoming of the management here IMO.
When the guidelines were released I took the time to read extensively through these as well as analyze the one question (#7)which seemed to be a direct response to KC’s original reply to the FDA’s attack. I? was originally a bit disappointed with the separation of stem cells being a deal breaker when it comes to the exclusion of oversight from the FDA. However the latest release on the 3 year window before enforcement would take place changes everything! IMO This means the FDA understands companies like USRM are onto something groundbreaking (which was admitted by Gottlieb) and want to be a part of it, but it has all happened so fast and under the radar that FDA doesn’t understand how they can control it and benefit from it. That’s the point folks, the Government/FDA gains a lot behind the scenes from big Pharma and if there is to be a “changing of the guard” in the future....then there better be a clear path out how the government/FDA will benefit from this. They are no dummies, right now the money and donations is in Big Pharma but if the money starts rolling into alternatives then they will want to be a part of this, which is clear, but they are not going to sell out their cash cow Big Pharma. Over time it will change and Gottlieb admits this, which is why IMO the 3 years was given before any adverse enforcement. Let this blossom into something that can hold a candle to Big Pharma and then in due time it will be accepted and approved. Thank god for the environment we live in with social media and word of mouth, because this will blow up and go viral and people will make a stand and demand rights to their bodies and their stem cells. It’s already happening, look at the crazy increase in revenues quarter after quarter! If the FDA didn’t see this as a viable treatment then they would have shut USRM down immediately not given a 3 year window. IMO the 3 year window is for the FDA to understand, and strategically plan! Think about it, if it was such a horrible scam then you think a 3 year window is warranted. There will always be a seat at the table for Big Pharma they have greased enough palms and played the game to earn that, in due time companies like USRM will have a seat at that table too but they will need to play the game which is becoming evident. It can and will be done, so much momentum here, Absolute no brainer here folks!
Anyone read Question #7 at the end of the document? Compare this to Comella’s reply to FDA about qualifying for an exception.
From Scott Gottlieb himself!!!!
“We’re at the beginning of a paradigm change in medicine with the promise of being able to facilitate regeneration of parts of the human body, where cells and tissues can be engineered to grow healthy, functional organs to replace diseased ones; new genes can be introduced into the body to combat disease; and adult stem cells can generate replacements for cells that are lost to injury or disease. This is no longer the stuff of science fiction. This is the practical promise of modern applications of regenerative medicine,” said FDA Commissioner Scott Gottlieb, M.D
With about 335 million total shares outstanding. I? would venture to guess between various IHUB users about 15-20% of these total shares are held with strong hands who are active just here. I? would imagine a lot more shares are held by strong hands who don’t take the time to share this on IHUB. IMO Most of us are not interested in selling shares anytime soon as we see the tremendous amount of future growth in this sector. This just needs one piece of news....just one piece! Something like RMAT, any indication of deregulation, or any other bone the FDA may throw us and this thing takes off and it will be extremely hard to get shares. Go back and look at the charts during RMAT and the PR about the potential 5M investment from GACP, now neither of these worked out to the extent we had hoped at the time... but look what happens to the PPS during the time of these being just a “possibility”. I? got news flash folks...RMAT, future investments from major players , FDA deregulation, and breakthrough technology and discoveries in this space are all still POSSIBLE and IMO PROBABLE. News can come Any day and when something solid does show up in the news feed, good luck getting shares! The CHASE will be fun to watch. I? think people will be surprised at how many of the shares won’t be for sale. In this low volume environment supply and demand is being controlled by the MM’s, but what happens when volume takes off on news? MM’s will need more shares but I know a few of us that will be smiling and holding! All just my Opinions, but I? do get up fairly early in the morning...and what is it they say about the early bird? Good luck to everyone this week!
Cmon everyone...what did you Xpecht was going to happen today? Between myself and the other major share holders we just gotta hold what we have and keep accumulating on days like yesterday and PPS will continue to rise over time. Hop on board why you can folks!
This is a long term play on stem cells having a place in the mainstream health and wellness industry. Currently it’s a boutique option and not widespread. The growth we all want is based on this being widespread which comes with time. The RMAT possibility would have fast tracked this growth but If you believe stem cells will gain popularity and regulations will break down over time then how can one not see this as a bargain investment. The days of flipping this are temporarily over since they temporarily stopped the pursuit of RMAT. Only upside from here with increasing revenues and exclusive rights to a propriety method (kits)that a large number of the clinics in this space seem to have embraced. As the space grows so does USRM, The financials have improved and should continue to improve, the PPS may not reflect this but Comella and Tomas have the commitment and resilience to grow this space and along the way fight the FDA and put them in their place! That was a major step, which shows even the FDA can’t hold back stem cells. Newsflash!! The FDA seems to have backed off and next should need to open doors due to compelling results and public demand! Not much talk about the fact the FDA backed off, however this is a major milestone. Sure it isn’t RMAT but it is a big step in the right direction! We all saw what happened during RMAT when there was a chance to get “fast track” approval. RMAT is still on the table and we may very will get it in due time, however if it’s a slow track to the same levels RMAT PPS reached then this sure looks opportunistic! Btw the financials were not nearly as good as they are now back during the RMAT days so if you consider better financials coupled with long term acceptance and potential RMAT designation = dollar land in my opinion. Just my opinions but I do play cards weekly with very smart people from time to time!
To whomever sold me the .0235 lot, I would appreciate more then a partial fill. Keep em coming and I have a nice fruit basket I will send your way for Xmas! We got a nice sell going on her people, fill up the cart!
Marketing position open in sunrise, FL. Anyone have a son/daughter in college out that way who we can plug into that position. Clearly the company is innovative from a scientific/medical standpoint but we can’t expect them to be marketing geniuses and great salespeople! They need help with the PR and marketing! This would speed up the increase in PPS in my opinion.
IMO A good earnings report, which we all expect, should put this back to .04 and then anything positive from FDA or more clarity on RMAT will get big money back in and go .10 plus. With This med technology it’s not a matter of if but when. It’s business people, every day or week Big Pharma can keep this at bay is millions of dollars in prescriptions for their business. Think Big Pharma may have a vested interest in keeping stocks like this down? Think they may donate to politician’s campaigns? Think the FDA is in regular communication with the government? Hmmm? Although I think we may have the one guy in office who’s political etiquette is a bit different then the status quo in the past where lobbying was widespread and prevailed. This is our best chance for de-regulation and getting USRM rolling!
I think the PR about the 287 clinics using the kits was Tomas’s way of letting the loyal shareholders know the quarterly financials are not going to disappoint. None of us knew how many clinics there were and now we do! Why on earth would there be a PR about going from 286 to 287, not a big deal in and of itself, unless there is a hidden message in there that a boatload of clinics have committed to the kits since the last quarter! And remember last quarter was record breaking! Can’t wait for the quarterly and the chase that follows!
Here she goes! Must be some good earnings coming out!
GREAT NEWS! The PR lets people know there are 287 clinics using their kits, which as Tomas has mentioned the kits are a vital part of their revenue and growth. I have been following this company for a while and didn’t know how widespread the kit usage and demand was. This should increase the revenue in the quarterly we see here soon IMO! I know people are impatient but if these kits are used in pain management treatments and there is a crackdown on OPIOD pain management then I think the long run looks promising! Just gotta get through the politics and BIG Pharma not wanting these types of treatments widespread! As people learn and demand rights to their stem cells USRM is in a good position to capitalize on the floodgates opening. Just my opinion but I am holding out for at least $1. Plenty of other great flipping opportunities on IHUB while I sit on this!
This will bounce quick and big! imho
This news plus the Good financials in the quarterly should get this moving!
Let’s get some news out for DR Murphy! That poor fella invested millions with bioheart and is old as dirt, is Tomas gonna show him some love and get the pps moving?
I'm long here holding 890k at an average below what we are trading at now. CEO Tomas is concerned with the stock manipulation, and false claims on message boards. It's easy for people to make claims and manipulate with no tangible company communication or press on a regular basis. The CEO puts time, energy, and company funds into lawyers/investigators....Some may think that time, energy, and money should be put towards a decent marketing/PR team. Or....there could be something really big brewing here that may surprise everyone including the manipulators....You all decide! All just my opinion but we should be in vegas by next spring just in time for the pool parties to kick off the nice weather! And I quote the great Axel Rose "all we need is just a little patience" Ha!
Ultimately what makes this move up in the long run is the clear path from the FDA. Which according to Tomas hasn't been clear! FDA and USRM are in a power struggle from what I can see. The letter provides more clarity to the path (which should be turnkey to follow)and makes someone at the FDA feel like they are doing their "job". Clearly this employee didn't get the memo Gottlieb is the new sheriff in town. These are simply growing pains to get a breakthrough treatment to market USRM is here for the long run like it or not.
(All above are simply my humble opinions)